The chronic use of Ang blockers was incriminated for increasing the risk of infection with the SARS-CoV-2 virus and in the unfavorable evolution of the disease in patients subjected with ACE inhibitors or ARBs for hypertension, cardiac disease, or diabetes, due to the upregulation of the ACE receptor following long-term inhibition. Here, ACE is linked to hypertensive disorder.